CLINICAL_TRIALS
trial_result
· 2024-04-18
Clinical Trial Update: Natalizumab and Chronic Inflammation [Phase 4]
Summary
Phase 4 clinical trial update for natalizumab in chronic inflammation (multiple sclerosis) has been terminated with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2024-04-18